Skip to main content
. 2023 Jun 5;14:1158364. doi: 10.3389/fimmu.2023.1158364

Table 7.

Spearman correlation for important parameters.

Variable r 95% C.I P
Contracting COVID & PD worsening* -0.2 (-0.51, -0.14) 0.25
Contracting & Duration of PD worsening 0.24 (-0.53, 0.11) 0.18
Medications & PD worsening 0.11 (-0.40, 0.20) 0.24
Duration of PD & PD worsening* 0.1 (-0.24, 0.43) 0.33
Duration of PD & Duration of Worsening 0.05 (-0.29, 0.38) 0.76
Age & PD Worsening* -0.2 (-0.50, 0.15) 0.08
Hesitancy & Side Effect Severity** 0.28 (-0.42, 0.18) 0.33
Age & Duration of PD worsening -0.23 (-0.53, 0.11) 0.18
Hesitancy & PD Worsening* 0.33 (-0.11, 0.42) 0.01
Side Effect Severity** & PD Worsening* 0.28 (-0.16, 0.49) 0.04
Vaccine Type & PD Worsening* 0.28 (-0.16, 0.32) 0.02
Vaccine Type & Duration of PD Worsening 0.32 (0.11, 0.34) 0.003
PD Worsening & Duration of PD Worsening 0.96 (0.93, 0.98) <0.001
Worsening after each dose of PD Worsening 0.82 (0.77, 0.85) <0.001

Spearman’s Correlation value (r) is between -1 to 1. Positive value indicates positive correlation, negative value indicates negative correlation.

*PD worsening here refers to severity of the reported worsening.

**Side effects severity refers to severity of general non-specific symptoms like fever, chills, headaches, fatigue, etc.

The important relationships with higher correlation coefficients are highlighted in the yellow box.